FY2024 Second Quarter Financial Results Presentation Summary of Q&A Session

FY2024 Second Quarter Financial Results Presentation Materials

FY2024 Second Quarter Summary of Consolidated Financial Statements

FY2024 First Quarter Financial Results Presentation Summary of Q&A Session

FY2024 First Quarter Financial Results Presentation Materials

FY2024 First Quarter Summary of Consolidated Financial Statements

Notice of Convocation of the 165th Ordinary General Meeting of Shareholders Other Matters Subject to the Electronic Provision

Notice of Convocation of the 165th Ordinary General Meeting of Shareholders

FY2023 Financial Results Presentation Summary of Q&A Session

FY2023 Financial Results Presentation Materials

FY2023 Summary of Consolidated Financial Statements

Announcement of Extraordinary Gains(Gain on Sale of Investment Securities)

FY2023 Third Quarter Financial Results Presentation Summary of Q&A Session

Announcement of Discontinuation of Development of a Norovirus Vaccine in an Overseas Consolidated Subsidiary and Recording of Extraordinary Loss

FY2023 Third Quarter Financial Results Presentation Materials

Notice Regarding Changes in Executive Officers

FY2023 Third Quarter Summary of Consolidated Financial Statements